Table VI.
LCA-based cognitive impairment level (n = 812) |
||||
---|---|---|---|---|
Severe n = 64 | Moderate n = 135 | Low Normal n = 333 | Normal n = 280 | |
Elevated inflammatory proteins | ||||
IRG1 | Ref | Ref | Ref | Ref |
IRG2 | 3.79 (1.72–8.36) | 3.93 (2.08–7.41) | 2.54 (1.48–4.34) | Ref |
IRG3 | 2.18 (0.61–7.78) | 3.18 (1.29–7.83) | 1.53 (0.69–3.38) | Ref |
Elevated neurotrophic proteins | ||||
NRG1 | Ref | Ref | Ref | Ref |
NRG2 | 0.31 (0.12–0.79) | 0.46 (0.24–0.88) | 0.62 (0.39–0.98) | Ref |
NRG3 | 0.85 (0.37–1.95) | 1.03 (0.55–1.95) | 1.00 (0.60–1.67) | Ref |
IRG2 defined by elevation of CRP or SAA with other proteins having little or modest elevations.
IRG3 defined by ≥3 other protein elevations without CRP and SAA elevations.
NRG2 defined by elevation of 2 of RANTES, BDNF, or ANG-1 with other proteins having little or modest elevations.
NRG3 defined by ≥3 other proteins elevated protein elevations without CRP and SAA elevations.
Values are adjusted OR (95% CI).
Bold values represent ORs for which the 95% confidence limits do not include 1; ie, significantly different from 1 at P < .05.
At 10 years of age for those with sustained elevated inflammatory and neurotrophic proteins (controlling for infant sex and maternal education).